2225 logo

Jinhai Medical Technology Limited Stock Price

SEHK:2225 Community·HK$6.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

2225 Share Price Performance

HK$0
-2.25 (-100.00%)
HK$0
-2.25 (-100.00%)
Price HK$0

2225 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with very low risk.

2 Risks
0 Rewards

Jinhai Medical Technology Limited Key Details

S$38.8m

Revenue

S$32.7m

Cost of Revenue

S$6.1m

Gross Profit

S$28.3m

Other Expenses

-S$22.2m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.0042
15.80%
-57.10%
41.6%
View Full Analysis

About 2225

Founded
2006
Employees
458
CEO
Zhenfei Wang
WebsiteView website
www.jin-hai.com.hk

Jinhai Medical Technology Limited, an investment holding company, provides minimally invasive surgery solutions, medical products, and related services in the People's Republic of China and Singapore. It also offers manpower outsourcing and ancillary services to building and construction contractors. In addition, the company provides IT services; construction ancillary services, such as warehousing, cleaning, and building maintenance services; and dormitory services. Further, it offers engineering design and consultancy services, as well as sells graphene material products. The company was formerly known as Jinhai International Group Holdings Limited and changed its name to Jinhai Medical Technology Limited in December 2023. The company was founded in 2006 and is headquartered in Wan Chai, Hong Kong. Jinhai Medical Technology Limited is a subsidiary of Full Fortune International Co., Ltd.

Recent 2225 News & Updates

Recent updates

No updates